BNP Paribas Financial Markets Has $456,000 Position in Pediatrix Medical Group, Inc. (NYSE:MD)

BNP Paribas Financial Markets boosted its stake in Pediatrix Medical Group, Inc. (NYSE:MD) by 87.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 34,776 shares of the company’s stock after purchasing an additional 16,256 shares during the period. BNP Paribas Financial Markets’ holdings in Pediatrix Medical Group were worth $456,000 at the end of the most recent reporting period.

Other institutional investors have also added to or reduced their stakes in the company. Pacer Advisors Inc. bought a new position in shares of Pediatrix Medical Group during the 4th quarter worth about $35,492,000. American Century Companies Inc. grew its stake in shares of Pediatrix Medical Group by 628.2% during the 4th quarter. American Century Companies Inc. now owns 1,739,323 shares of the company’s stock worth $22,820,000 after acquiring an additional 1,500,485 shares during the period. Oberweis Asset Management Inc. bought a new stake in shares of Pediatrix Medical Group in the fourth quarter valued at approximately $6,122,000. Renaissance Technologies LLC boosted its holdings in shares of Pediatrix Medical Group by 117.4% in the fourth quarter. Renaissance Technologies LLC now owns 838,800 shares of the company’s stock worth $11,005,000 after acquiring an additional 453,000 shares during the period. Finally, Boston Partners increased its position in shares of Pediatrix Medical Group by 25.2% during the fourth quarter. Boston Partners now owns 1,956,353 shares of the company’s stock valued at $25,922,000 after buying an additional 393,600 shares during the period. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Down 3.1%

Shares of Pediatrix Medical Group stock opened at $13.53 on Monday. The stock has a market capitalization of $1.16 billion, a PE ratio of -11.27, a price-to-earnings-growth ratio of 1.74 and a beta of 1.26. The company has a 50-day simple moving average of $13.77 and a two-hundred day simple moving average of $14.08. Pediatrix Medical Group, Inc. has a 52-week low of $6.62 and a 52-week high of $17.67. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60.

Pediatrix Medical Group (NYSE:MD) last posted its earnings results on Tuesday, May 6th. The company reported $0.33 EPS for the quarter, topping analysts’ consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million during the quarter, compared to the consensus estimate of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The firm’s revenue was down 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.20 EPS. On average, analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current fiscal year.

Wall Street Analyst Weigh In

MD has been the topic of several research analyst reports. UBS Group decreased their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research report on Monday, May 12th. Truist Financial decreased their target price on Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating for the company in a report on Friday, April 11th. Finally, Macquarie raised their target price on Pediatrix Medical Group from $19.00 to $20.00 and gave the company an “outperform” rating in a research note on Thursday, May 8th. Four equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $16.67.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.